<- Go Home
The Oncology Institute, Inc.
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Market Cap
$304.4M
Volume
1.7M
Cash and Equivalents
$33.6M
EBITDA
-$29.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$76.4M
Profit Margin
15.20%
52 Week High
$4.88
52 Week Low
$1.62
Dividend
N/A
Price / Book Value
-19.37
Price / Earnings
-5.66
Price / Tangible Book Value
-8.97
Enterprise Value
$374.6M
Enterprise Value / EBITDA
-20.07
Operating Income
-$36.1M
Return on Equity
999.19%
Return on Assets
-13.37
Cash and Short Term Investments
$33.6M
Debt
$103.8M
Equity
-$15.7M
Revenue
$502.7M
Unlevered FCF
-$12.3M
Sector
Health Care Providers and Services
Category
N/A